Literature DB >> 2414112

Further characterization and subcellular localization of Sm and U1 ribonucleoprotein antigens.

W J Habets, J H Berden, S O Hoch, W J Van Venrooij.   

Abstract

Sera from patients with systemic autoimmune diseases often contain antibodies against small nuclear ribonucleoprotein (snRNP) particles. Anti-Sm antibodies react with the entire set of U1, U2, U4, U5 and U6 (U1-U6) RNP particles whereas anti-(U1)RNP sera specifically recognize particles containing U1 RNA. Here we performed semi-quantitative immunoblotting using 16 human anti-Sm, 15 human anti-(U1)RNP sera and two mouse monoclonal antibodies to establish which snRNA-associated proteins carry antigenic determinants. Almost every (15/16) human anti-Sm sera recognized epitopes present on a 28-kDa (B/B') protein doublet and on a 16-kDa (D) polypeptide. Nine anti-(U1)RNP sera also recognized the B/B' doublet, but in all cases a much stronger reaction was observed with one or more of the specifically U1 RNA-associated 70 kDa, A or C antigens. With affinity-purified antibody fractions eluted from individual antigen bands on nitrocellulose blots it is shown that the anti-Sm-reactive polypeptides B/B' and D contain common epitopes. We also report the finding of one human anti-Sm serum with exclusive specificity for the B/B' doublet and a mouse monoclonal anti-Sm antibody recognizing only the D protein, indicating that these antigens also carry unique epitopes. In immunoprecipitation assays, purified anti-B/B' and -D antibodies react with (U1-U6) RNP while purified anti-70 kDa, anti-A and anti-C antibodies precipitate exclusively U1 RNP particles. Finally, we established the subcellular localization of Sm and U1 RNP antigens using a biochemical cell fractionation procedure. Part of the 70 kDa and B/B' antigens were found in a nuclease and high salt-resistant nuclear substructure, usually referred to as nuclear matrix, while the A and D antigens could be extracted completely from HeLa nuclei by ribonuclease treatment and subsequent high salt extraction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414112     DOI: 10.1002/eji.1830151006

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  28 in total

Review 1.  B-cell epitopes of Sm autoantigens.

Authors:  L A Rokeach; S O Hoch
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

2.  Heterogeneity of RNP and Sm autoantigens in relation to the cell sources and the activated state of the cells.

Authors:  F Hiepe; K Yamamoto; A Takeuchi; E Apostoloff; T Miyamoto
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

3.  The La antigen shuttles between the nucleus and the cytoplasm in CV-1 cells.

Authors:  M Bachmann; K Pfeifer; H C Schröder; W E Müller
Journal:  Mol Cell Biochem       Date:  1989-02-21       Impact factor: 3.396

Review 4.  cDNA cloning of small nuclear and cytoplasmic RNA-associated proteins.

Authors:  A van Dam; I Winkel; R Smeenk; T Cuypers
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

5.  Polypeptide components of Drosophila small nuclear ribonucleoprotein particles.

Authors:  T Paterson; J D Beggs; D J Finnegan; R Lührmann
Journal:  Nucleic Acids Res       Date:  1991-11-11       Impact factor: 16.971

6.  Comparison of assay systems for detecting antibodies to nuclear ribonucleoproteins.

Authors:  P Merryman; P Louie
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

7.  Use of recombinant RNP peptides 70K and A in an ELISA for measurement of antibodies in mixed connective tissue disease: a longitudinal follow up of 18 patients.

Authors:  D J de Rooij; W J Habets; L B van de Putte; M H Hoet; A L Verbeek; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

8.  Regulation of the anti-Sm autoantibody response in systemic lupus erythematosus mice by monoclonal anti-Sm antibodies.

Authors:  R A Eisenberg; D S Pisetsky; S Y Craven; J P Grudier; M A O'Donnell; P L Cohen
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

9.  Anti-ribosomal antibodies bind the Sm proteins D and B/B'.

Authors:  L Caponi; S Bombardieri; P Migliorini
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

10.  Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting.

Authors:  C G Kallenberg; A A Wouda; M H Hoet; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.